Synthesis of 9-substituted derivatives of berberine as anti-HIV agents. 2011

Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
Department of Natural Products, National Institute of Pharmaceutical Education and Research, Sector 67, SAS Nagar, Punjab 160062, India.

Naturally occurring protoberberine alkaloids, berberine and berberrubine along with 9-substituted derivatives of berberine were assessed for the anti-human immunodeficiency virus (HIV) activity. Berberine was found to be the most active compound with an EC(50) of 0.13 μM against HIV-1 NL4.3 virus in CEM-GFP cell lines. Berberrubine and two other compounds were found to be less active than berberine, at the same time they were less toxic than berberine. Enzyme based assay suggested that the anti-HIV activity of berberine and its analogs might be due to RTase inhibitory activity and some additional mechanisms.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001599 Berberine An alkaloid from Hydrastis canadensis L., Berberidaceae. It is also found in many other plants. It is relatively toxic parenterally, but has been used orally for various parasitic and fungal infections and as antidiarrheal. Umbellatine
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
February 2020, Molecules (Basel, Switzerland),
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
May 1996, Farmaco (Societa chimica italiana : 1989),
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
August 2006, Bioorganic & medicinal chemistry letters,
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
May 2016, American journal of Alzheimer's disease and other dementias,
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
May 2019, International journal of molecular sciences,
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
June 2018, Bioorganic & medicinal chemistry letters,
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
January 2018, Anti-cancer agents in medicinal chemistry,
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
October 2016, Bioorganic & medicinal chemistry letters,
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
January 2020, Beilstein journal of organic chemistry,
Hardik S Bodiwala, and Sudeep Sabde, and Debashis Mitra, and Kamlesh Kumar Bhutani, and Inder Pal Singh
April 2007, Archiv der Pharmazie,
Copied contents to your clipboard!